Position in RDNT
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$5,261,261
-$1,383,992 QoQ
Shares Held
94,136
+1.1% QoQ
Ownership
0.120%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RDNT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026First Eagle Investment Management, LLC holds $485,303,949 across 5 Diagnostics & Research names. RDNT ranks #3 (1.1% of the industry book) .
All Filings in RDNT
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,261,261 | 94,136 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $6,645,253 | 93,136 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $6,823,538 | 89,536 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,961,767 | 52,043 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $3,040,029 | 61,143 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $5,939,403 | 85,043 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $7,046,068 | 101,543 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $5,446,741 | 92,443 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $4,741,576 | 97,443 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $2,609,245 | 75,043 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $1,694,021 | 60,093 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $1,391,177 | 42,648 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $1,680,714 | 67,148 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,669,241 | 88,648 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $2,099,061 | 103,148 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $2,050,237 | 118,648 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $1,401,010 | 62,629 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $722,640 | 24,000 | Shares | Sole | 2022-02-10 | |
| No filing history on record for this holder in this stock. | ||||||